| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.535 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.535 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
PKP3 |
PKP3: Plakophilin-3 |
0.535 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
0.535 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
PKP4 |
PKP4: Plakophilin-4 |
0.535 |
Evidence |
|
| MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
BMF |
BMF: Bcl-2-modifying factor |
0.535 |
Evidence |
|
| MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
0.535 |
Evidence |
|
| BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
0.535 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
GRB10 |
IPI00012752 |
0.535 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
JAK1 |
|
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
0.535 |
Evidence |
|
| PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.535 |
Evidence |
|